Showing results (31-40 of 237) with videos related to
Sort By:
Pageof 24
The Canadian Journal of Cardiology|August 17, 2004
Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?Jacques GenestCardiology in Review|January 16, 2002
Genetics and prevention: a new look at high-density lipoprotein cholesterolJacques GenestThe Canadian Journal of Cardiology|April 14, 2010
C-reactive protein: risk factor, biomarker and/or therapeutic target?Jacques GenestJACC. Basic to Translational Science|August 1, 2018
Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell CalcificationBin Yu, Anouar Hafiane, George Thanassoulis, et al.Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.Cellular Signalling|December 26, 2021
Apolipoprotein A-I carboxy-terminal domain residues 187-243 are required for adiponectin-induced cholesterol effluxAnouar Hafiane, Ioanna Gianopoulos, Mary G Sorci-Thomas, et al.Current Opinion in Lipidology|September 28, 2021
Current models of apolipoprotein A-I lipidation by adenosine triphosphate binding cassette transporter A1Anouar Hafiane, Ioanna Gianopoulos, Mary G Sorci-Thomas, et al.Metabolism: Clinical and Experimental|January 11, 2020
High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseasesAnouar Hafiane, Elda Favari, Stella S Daskalopoulou, et al.European Journal of Medical Research|April 11, 2025
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemiaAnouar Hafiane, Annalisa Ronca, Matteo Incerti, et al.BBA Advances|April 21, 2023
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophagesAnouar Hafiane, Alessandro Pisaturo, Annalisa Ronca, et al.Pageof 24